0.00Open0.02Pre Close0 Volume8 Open Interest140.00Strike Price0.00Turnover6467.04%IV28.92%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier-6DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0062Delta0.0017Gamma5430.50Leverage Ratio-104.9904Theta0.0000Rho33.88Eff Leverage0.0000Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet